Press Releases
Oncodesign awarded accreditation of its research center by international...
Oncodesign, a contract research laboratory for the discovery of new anticancer therapies, today announces that its Dijon-based research center has received AAALAC certification. ...
Press Releases
Cubist Enrolls First Patient in Phase 3 Efficacy Studies...
Cubist Pharmaceuticals Inc. today announced the initiation of Phase 3 efficacy studies of bevenopran (previously known as CB-5945) in patients with chronic non-cancer pain and...
Press Releases
Alize Pharma launches the first Phase I clinical trial...
Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of the...
Press Releases
Impax Laboratories Launches Authorized Generic TRILIPIX® Delayed Release Capsules,...
Impax Laboratories Inc. today announced that it is commencing shipment of authorized generic TRILIPIX® (fenofibric acid) delayed release capsules 45 mg and 135 mg through...
Press Releases
Tetrahedron announces that Selisseo(R) received a market authorization for...
Tetrahedron, designing and developing rare natural and synthetic antioxidants for the health nutrition, dermocosmetics and pharmacy sectors, today announces that Selisseo(R) has received marketing authorization...
Press Releases
Medivir Streamlines Operations by Divesting Cross Pharma, its Parallel...
Medivir AB (STO:MVIR-B) today announced that the company has signed an agreement to sell its wholly owned subsidiary Cross Pharma AB to Unimedic AB a...
Press Releases
Quintiles Named Britain’s Healthiest Large Company
Quintiles has been named “Britain’s Healthiest Large Company” in the first survey of its kind to identify organizations in Britain with outstanding employee health and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.